[The incidence of pulmonary embolism as a measure of evaluation of general thrombosis prevention. 4 years of clinical trials with Thrombodym (Neodymsulfo-isonicotinate)].
D000925:Anticoagulants; D006801:Humans; D015994:Incidence; D007539:Isonicotinic Acids; D009354:Neodymium; D011655:Pulmonary Embolism; D013927:Thrombosis
D000925:Anticoagulants; D007539:Isonicotinic Acids; D009354:Neodymium
ANTICOAGULANTS; ISONICOTINIC ACID; NEODYMIUM; PULMONARY EMBOLISM; THROMBOSIS